Seres Therapeutics names Richard Kender as interim CEO
Go back to Seres Therapeutics names Richard Kender as interim CEO| (NASDAQ: BCYC) | Delayed: 4.35 +0.14 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.21 | 52 Week High | $ | |||
| Open | $4.22 | 52 Week Low | $ | |||
| Day High | $4.40 | P/E | N/A | |||
| Day Low | $4.21 | EPS | $ | |||
| Volume | 353,690 | |||||
| (NASDAQ: MCRB) | Delayed: 7.74 -0.2 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $44.51 | |||
| Open | $7.95 | 52 Week Low | $8.05 | |||
| Day High | $8.06 | P/E | N/A | |||
| Day Low | $7.48 | EPS | $0.00 | |||
| Volume | 130,835 | |||||
